Recent Updates
Recently added Catalysts
EBS Positive Sentiment Score: 65/100

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024

Wednesday, October 23, 2024 1 min read
Key Takeaway: Emergent BioSolutions Inc. plans to host a conference call on November 6, 2024, to discuss its financial results for the third quarter of 2024. During the call, the company will cover recent business developments and provide a financial outlook for the full year 2024. Participants can join the call via webcast or telephone. Details for accessing the call and a replay will be available on the company's Investors page.

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions is actively engaging with investors through a conference call.
  • The scheduled conference call includes discussions on recent business developments.
  • The company will provide a financial outlook for the full year 2024.

Full Press Release Details

GAITHERSBURG, Md., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, November 6, 2024, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2024, recent business developments, and financial outlook for full year 2024.
Webcast & Conference Call Information
Participants can access the conference call live via webcast. To join via telephone, please use the following dial-in details:
U.S. / New York: +1-646-968-2525
U.S. & Canada (Toll Free): +1-888-596-4144
Conference ID: 5259189
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
Executive Vice President, CFO
Vice President, Communications
mediarelations@ebsi.com

Frequently Asked Questions

When is Emergent BioSolutions' next conference call?

The next conference call is scheduled for November 6, 2024, at 5:00 pm ET.

How can I join the conference call?

You can join the call via live webcast or by telephone using provided dial-in details.

What topics will be discussed in the call?

The call will cover Q3 2024 financial results, business developments, and the full-year outlook.

Is there a replay available for the conference call?

Yes, a replay will be accessible on Emergent’s Investors page after the call.

What is the conference ID for the call?

The conference ID for the call is 5259189.

Tags: EBS Viatris Investor Conferences Healthcare Emergent BioSolutions financial results conference call business developments
Last updated: Oct 23, 2024